Cases
Search
Statistics
Estimate
SEARCH
Show Filters
Decision Date
December, 2019
(1)
August, 2019
(2)
March, 2019
(1)
January, 2019
(1)
Decision
Complaint denied
(5)
Complainant
Regeneron Pharmaceuticals, Inc.
(1)
Pharrning Group N.V.
(1)
Pharnext
(1)
Nedbank Limited
(1)
Eve Distribuciones S.A.S.
(1)
Respondent
王俊东(wang jun dong)
(1)
Zhang Guo Jie
(1)
Wang Bo, Xiang Rong (Shang Hai) Sheng Wu Ke Ji You Xian Gong Si
(1)
Perfect Privacy, LLC. / Benito Fidel Garcia Acosta, Comercializadora Multidrogas Del Caribe Limitada
(1)
Hu Zhe, Bei Jing Rui Cheng Hai Hui Jian Kang Ke Ji You Xian Gong Si
(1)
Panelist
Willem J. H. Leppink
(1)
Rachel Tan
(1)
Peter J. Dernbach
(1)
Karen Fong
(1)
Dr. Hong Xue
(1)
Douglas Clark
(1)
Daniel Peña
(1)
Complainant Country
France
(2)
United States
(1)
South Africa
(1)
Netherlands
(1)
Complainant Representative
Ohlandt, Greeley, Ruggiero & Perle, LLP
(1)
Nameshield
(1)
Cabinet Lavoix
(1)
Arnold & Siedsma B.V.
(1)
Adams & Adams Attorneys
(1)
Respondent Country
China
(5)
Respondent Representative
HengDu Law Firm
(1)
Beijing Beihui Law Firm
(1)
Respondent Reply
Yes
(3)
No
(2)
RDNH Status
Yes
(1)
Case Language
English
(5)
Case Particular
D
(5)
Number Of Domains
1
(5)
Domain Extension
com
(4)
online
(1)
Domain Extension Type
gTLD
(4)
newgTLD
(1)
Domain Length
6
(1)
7
(2)
11
(2)
Includes Hyphen
Yes
(1)
No
(4)
Includes Number
No
(5)
Includes Letter
Yes
(5)
Domain Registrar
Alibaba Cloud Computing Ltd. d/b/a HiChina (www.net.cn)
(4)
Xin Net Technology Corporation
(1)
5
cases found.
Decision: Complaint denied
Decision Date: 2019
Respondent Country: China
Reset Search
eyelaa.com
Complaint denied
WIPO D2019-2569
(Decision Date: Dec. 31, 2019)
multidrogas.com
Complaint denied
WIPO D2019-1576
(Decision Date: Aug. 31, 2019)
netbank.online
Complaint denied
(RDNH)
WIPO D2019-1183
(Decision Date: Aug. 6, 2019)
pharnex.com
Complaint denied
WIPO D2019-0035
(Decision Date: March 11, 2019)
cc-pharming.com
Complaint denied
WIPO D2018-2499
(Decision Date: Jan. 18, 2019)
Stay updated! Get new cases and decisions by daily email.
leave this field blank to prove your humanity
Subscribe
Scroll